Volatility Spikes As Rates Drop… And China’s Growing Chip Demand 10/16/25
CNBC's "Fast Money"
00:00
How crowded is the MASH (liver disease) drug market?
Madrigal CEO Bill Sibold explains ResDifera launch progress, market penetration, competition, and the large addressable patient opportunity.
Play episode from 39:10
Transcript
